cosopt dorzolamide hydrochloride 20mg and timolol maleate 5mg per ml eye drop bottle
mundipharma pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: benzalkonium chloride; mannitol; sodium hydroxide; water for injections; hyetellose; sodium citrate dihydrate - cosopt is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concominant therapy is appropriate.
cosdor dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drop bottle
viatris pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops - excipient ingredients: mannitol; benzalkonium chloride; hyetellose; water for injections; sodium citrate dihydrate; sodium hydroxide - cosdor is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.
cosopt preservative-free dorzolamide (as hydrochloride) 20mg/ml and timolol (as maleate) 5mg/ml single dose eye drop ampoule
mundipharma pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: mannitol; sodium hydroxide; water for injections; hyetellose; sodium citrate dihydrate - cosopt preservative free is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concominant therapy is appropriate.
dorzolamide/timolol ju 20/5 dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drops solution bottle
arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: benzalkonium chloride; water for injections; sodium hydroxide; sodium citrate dihydrate; hyetellose; mannitol - the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.
dorzolamide/timolol jno 20/5 dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drops solution bottle
arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: sodium hydroxide; benzalkonium chloride; hyetellose; water for injections; mannitol; sodium citrate dihydrate - the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.
dorzolamide/timolol jn 20/5 dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drops solution bottle
arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: sodium citrate dihydrate; benzalkonium chloride; mannitol; hyetellose; sodium hydroxide; water for injections - the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.
dorzolamide/timolol juno 20/5 dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drops solution bottle
arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: hyetellose; sodium citrate dihydrate; mannitol; sodium hydroxide; benzalkonium chloride; water for injections - the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.
vizo-pf dorzolatim dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drop solution multi-dose bottle
aft pharmaceuticals pty ltd - dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml); timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: sodium hydroxide; hyetellose; mannitol; water for injections; sodium citrate - vizo-pf dorzolatim is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.
timolol mlabs 0.25% timolol (as maleate) 2.5 mg/ ml eye drops solution bottle
micro labs pty ltd - timolol maleate, quantity: 3.4 mg/ml (equivalent: timolol, qty 2.5 mg/ml) - eye drops, solution - excipient ingredients: sodium hydroxide; dibasic sodium phosphate dodecahydrate; benzalkonium chloride; water for injections; monobasic sodium phosphate dihydrate - timolol ophthalmic solution is indicated for the reduction of elevated intraocular pressure.,in clinical trials it has been shown to reduce intraocular pressure in:,patients with ocular hypertension,patients with chronic open-angle glaucoma,aphakic patients with glaucoma.
timolol mlabs 0.5% timolol (as maleate) 5 mg/ml eye drops solution bottle
micro labs pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: water for injections; monobasic sodium phosphate dihydrate; sodium hydroxide; dibasic sodium phosphate dodecahydrate; benzalkonium chloride - timolol ophthalmic solution is indicated for the reduction of elevated intraocular pressure.,in clinical trials it has been shown to reduce intraocular pressure in:,patients with ocular hypertension,patients with chronic open-angle glaucoma,aphakic patients with glaucoma